Table 1.
Mice | Treatment | % Weight change during the 16 weeks of treatment | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 10 | 11 | 12 | 13 | 15 | 16 | ||
3xTg‐AD (n = 17) | MB | 0 | −0.02 ± 2.22% | −0.82 ± 2.11% | 1.44 ± 2.26% | −1.88 ± 1.81% | 2.30 ± 1.42% | 1.84 ± 1.58% | 1.56 ± 1.35% | 1.66 ± 1.10% | 2.94 ± 0.99% | 3.36 ± 1.11% | 4.74 ± 1.41% | 4.00 ± 1.18% | 5.08 ± 1.44% |
3xTg‐AD (n = 14) | CTL | 0 | −6.05 ± 3.50% | −0.48 ± 3.89% | −2.53 ± 2.84% | −2.48 ± 4.02% | 0.60 ± 4.46% | 1.13 ± 4.60% | 0.87 ± 4.79% | 0.29 ± 4.79% | 1.06 ± 4.03% | 0.84 ± 4.55% | 0.99 ± 4.62% | −1.83 ± 3.68% | 0.53 ± 3.43% |
NonTg (n = 13) | MB | 0 | 0.48 ± 3.11% | 0.20 ± 1.84% | 0.58 ± 1.84% | 1.51 ± 1.63% | −0.35 ± 1.77% | 0.73 ± 1.76% | −0.68 ± 1.92% | 0.28 ± 1.34% | 0.48 ± 1.15% | −1.34 ± 1.3% | 0.30 ± 1.66% | 1.11 ± 1.60% | 1.36 ± 1.64% |
NonTg (n = 10) | CTL | 0 | 3.15 ± 1.88% | 2.65 ± 1.64% | −0.37 ± 7.32% | 3.35 ± 2.16% | 4.72 ± 2.47% | 6.90 ± 2.80% | 5.76 ± 2.70% | 6.76 ± 2.53% | 6.53 ± 2.30% | 5.66 ± 2.65% | 6.50 ± 2.80% | 6.56 ± 2.79% | 7.17 ± 2.79% |